Vincerx Pharma, Inc. SC 13G and SC 13G/A reports

Location
260 Sheridan Avenue, Suite 400, Palo Alto, CA
Fiscal year end
December 31
Data updated at
11/12/2024, 09:30 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report SC 13G May 3, 2024
SC 13G/A Report Apr 9, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G Report Feb 13, 2024
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 13, 2024
SC 13G/A Report Feb 5, 2024
SC 13G Report SC 13G Feb 14, 2023
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 13, 2023
SC 13G/A Report SC 13G/A Feb 10, 2023
SC 13G/A Report Feb 10, 2023
SC 13G Report Feb 8, 2023
SC 13G/A Report Dec 29, 2022
SC 13G/A Report AMENDMENT NO. 1 Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report VINCERX PHARMA, INC. Feb 14, 2022
SC 13G/A Report AMENDED SC 13G Feb 11, 2022
SC 13G Report VINCERX PHARMA, INC. Feb 10, 2022
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Nov 22, 2021
SC 13G Report Sep 28, 2021
SC 13G Report SAGE RHINO CAPITAL, LLC Aug 4, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G Report Feb 16, 2021
SC 13G Report Feb 16, 2021
SC 13G Report SC 13G Jan 4, 2021
SC 13G Report Mar 16, 2020
SC 13G Report SCHEDULE 13G Mar 16, 2020